Cash & equivalents decreased 24.3%
Cash & equivalents changed -24.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -24.3% from the comparable as-filed period.
Net income changed -171.1% from the comparable as-filed period.
Operating income changed -322.1% from the comparable as-filed period.
Operating margin changed -4725 basis points from the comparable as-filed period.
Research & development changed -20.6% from the comparable as-filed period.
Stock-based compensation changed -73.0% from the comparable as-filed period.
Gross margin changed +142 basis points from the comparable as-filed period.
Gross profit changed -6.2% from the comparable as-filed period.
Revenue changed -7.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.